Outlook Therapeutics (OTLK) Free Cash Flow Growth (3y) (2018 - 2026)
Outlook Therapeutics (OTLK) Free Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
24.91% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
20.11% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
14.71% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Outlook Therapeutics |
63.14 Mn |
55.40 Mn |
-21,888.00 |
1.19% |
| Date | Value |
|---|
| Mar 31, 2026 |
1.19% |
| Dec 31, 2025 |
-18.84% |
| Sep 30, 2025 |
-6.49% |
| Jun 30, 2025 |
17.38% |
| Mar 31, 2025 |
-4.98% |
| Dec 31, 2024 |
0.07% |
| Sep 30, 2024 |
-23.62% |
| Jun 30, 2024 |
1.14% |
| Mar 31, 2024 |
-17.93% |
| Dec 31, 2023 |
0.74% |
| Sep 30, 2023 |
-1.80% |
| Jun 30, 2023 |
-30.44% |
| Mar 31, 2023 |
-4.64% |
| Dec 31, 2022 |
-10.08% |
| Sep 30, 2022 |
-24.35% |
| Jun 30, 2022 |
-23.99% |
| Mar 31, 2022 |
-31.46% |
| Dec 31, 2021 |
-3.14% |
| Sep 30, 2021 |
2.36% |
| Jun 30, 2021 |
-32.38% |
